A B S T R A C T This study was designed to provide direct information on the in vivo metabolism in man of free (unesterified) the a-and fB-lipoproteins increased for 3 h. During this period the a-free cholesterol specific activity was higher than the ,B specific activity. After administration of VLDL and LDL labeled with free cholesterol, the a-free cholesterol specific activity reached a peak value within 20 min, at which time it was considerably lower than the 13-free cholesterol specific activity. When HDL labeled with free cholesterol was administered, a precursor product relationship was observed between the a-free cholesterol (precursor) and ,3-free cholesterol (product) specific activities.
A B S T R A C T This study was designed to provide direct information on the in vivo metabolism in man of free (unesterified) cholesterol in the major lipoprotein classes. Five 9 h, and the a(HDL) and 13 (LDL + VLDL) lipoproteins were quickly separated by heparin-manganese precipitation to prevent ex vivo exchange of free cholesterol. After the administration of ['4C ]mevalonic acid the specific activity (disintegrations per minute/micromole) of free cholesterol in the a-and fB-lipoproteins increased for 3 h. During this period the a-free cholesterol specific activity was higher than the ,B specific activity. After administration of VLDL and LDL labeled with free cholesterol, the a-free cholesterol specific activity reached a peak value within 20 min, at which time it was considerably lower than the 13-free cholesterol specific activity. When HDL labeled with free cholesterol was administered, a precursor product relationship was observed between the a-free cholesterol (precursor) and ,3-free cholesterol (product) specific activities.
A multicompartmental model was developed that contained the simplest structure necessary to fit all of the data obtained. The kinetic analysis revealed the presence of extensive exchange ,umol/min) of free cholesterol between HDL and a tissue pool(s) enriched with newly synthesized free cholesterol. It was found that virtually all (>95%) of the free cholesterol in the ,B-lipoproteins (LDL+VLDL) cycles directly through HDL. The free cholesterol in LDL appears to behave in the same fashion as the free cholesterol in VLDL.
The results show that there are marked differences in the kinetic behavior of the free cholesterol fractions of a-and ,B-lipoproteins. There is extensive recycling of free cholesterol between HDL and tissue pools, and between HDL and the ,8-lipoproteins; this recycling has been quantitated. The findings support the view that in vivo, the free cholesterol in HDL plays a central role in exchange reactions and in the vascular-tissue cholesterol transport system. INTRODUCTION It has been customary to consider lipoprotein free (unesterified) cholesterol as one homogeneous plasma compartment both kinetically and metabolically because of the rapid exchange of free cholesterol observed between the lipoprotein classes. When labeled cholesterol is added to plasma or administered in vivo to rat or man and the lipoproteins are separated, it has been consistently observed that the specific activities of the free cholesterol fraction of the very low density lipoprotein (VLDL),' low density lipoprotein (LDL), ' Abbreviations used in this paper: a, Lipoproteins in the supernate after treatment of plasma with heparin-manganese (considered identical to HDL in this paper); 13, lipoproteins in the precipitate following treatment of plasma with heparin-manganese; C(n), compartment n in the model; DBED, dibenzylethylenediamine; FC, free (unesterified) cholesterol; HDL, high density lipoprotein, d = 1.063 -1.21; L(n, n), fraction of cholesterol in compartment n which leaves compartment n per minute; L(m, n), fraction of cholesterol in compartment n which is transported to compartment m per minute; LCAT, lecithin-cholesterol acyltransferase (E.C. 2 (2) . However, it should be pointed out that the observations made in these investigations were based primarily on the isolation of lipoproteins by ultracentrifugation, which takes several days and also on plasma specimens obtained several hours to days after the administration of labeled compounds. However, when the ex vivo exchange of cholesterol was prevented by rapidly separating the lipoproteins and when the plasma was sampled at early time intervals after labeled mevalonic acid administration, the a-lipoprotein free cholesterol was shown to have a higher specific activity than the s-lipoprotein free cholesterol for several hours in the baboon (3). There is also indirect evidence suggesting that lipoprotein free cholesterol is not metabolically homogeneous. An important function of lipoprotein free cholesterol related to the catabolic degradation of cholesterol in man has recently been reported. Multicompartmental kinetic analysis (4) of cholesterol metabolism in man has shown that lipoprotein free cholesterol is the major precursor substrate for bile acid synthesis and biliary cholesterol. Further examination of the metabolism of the lipoprotein free cholesterol fractions indicated that HDL-free cholesterol was preferred over LDL-free cholesterol for bile acid synthesis and biliary cholesterol secretion (5) (6) (7) . In addition, the free cholesterol in HDL, but not in VLDL or LDL, is used as a substrate for the lecithin-cholesterol acyltransferase (E.C. 2.3.1.43) (LCAT) enzyme (3, 8) .
HDL cholesterol is of great interest as a coronary risk factor. The plasma HDL cholesterol concentration has been shown to correlate inversely with the incidence of coronary artery disease (9) . However, the mechanism by which HDL offers protection is not known. If HDL-free cholesterol is metabolized differently than VLDL-and LDL-free cholesterol, i.e., if heterogeneity exists in the plasma free cholesterol, the protective effect of HDL might potentially be determined.
In the present communication, direct evidence is presented in man to show that plasma free cholesterol is heterogeneous. Subjects were administered isotopic free cholesterol in HDL, LDL, or VLDL, and
[14C]mevalonic acid. There were large differences be-C(n) in micromoles; MVA, mevalonic acid; NSC, newly synthesized cholesterol; R(m, n), micromoles of free cholesterol transported from compartment n to compartment m per minute; Turnover time, 1+.L(n, n), the time required for that quantity which is equal to the pool size, M(n), to move out of C(n); U., rate of entry of newly synthesized cholesterol into C(n) in (10) , by silicic acid column chromatography (11) , and by thin-layer chromatography on silica gel G with a solvent system of petroleum ether/diethyl ether/acetic acid (89:11:3 vol/vol/vol).
Preparation of each labeled lipoprotein was carried out from a fresh fasting sample of the subject's blood. Five (12) . Briefly, the filter paper strips were removed and the P-lipoproteins were precipitated from the plasma with heparin MnCl2 (13 (15), the lower chloroform phase was collected and subjected to silicic acid column chromatography (11) to separate the free cholesterol from esterified cholesterol.
Lipoprotein-free cholesterol mass was determined on an aliquot of the free cholesterol column fraction by gas liquid chromatography using coprostanol as the internal standard. The stationary phase was 3% SP 2401 (Supelco, Inc., Bellefonte, PA). Carrier free cholesterol was added to another aliquot of the free cholesterol fraction, the digitonide formed, isolated, dissolved in methanol, and "C or 3H activity was determined by liquid scintillation counting in Liquifluor (New England Nuclear). The isolated digitonides were checked for the presence of labeled contaminants by cleaving the digitonide with pyridine and determining the distribution of radioactivity on TLC. Virtually all the (>99%) radioactivity was recovered in the free cholesterol zone.
Radioactivity was determined in a Mark III Liquid Scintillation Counter (Tracor Analytic Inc., Silver Springs, MD); quench correction was applied using the external standard method.
RESULTS
Lipoprotein cholesterol concentrations. The plasma concentrations of a and , free cholesterol for the five subjects during the experiments are shown in Table  I . There was a wide range of a-FC concentration from subject to subject ,umol/dl). However, within each subject the a-FC concentration was constant during the course of the experiment as denoted by the small SEM. Also, no trends in the concentrations were noted during each experiment. The ,B-FC concentrations varied less from subject to subject and were also constant within each subject. No trends were noted in the ,B-FC levels. The constancy of the plasma lipoprotein free cholesterol and esterified cholesterol concentrations are suggestive of a steady state of cholesterol metabolism during the 9 h to 3 d of the experiments.
Specific activity data. Two factors were found to be critical in demonstrating differences in the kinetic behavior of the free cholesterol of the a-and B-lipoproteins. The first was the rapid separation of the lipoproteins to minimize ex vivo cholesterol exchange after the blood specimen was taken from the subject and second was frequent sampling of blood during the first few hours after administration of labeled preparations. Blood samples were obtained from subjects 2, 4, and 5, at intervals during the initial 3 h after administration of labels. One aliquot of each blood sample was subjected to ultracentrifugal isolation of HDL, LDL, and VLDL, and from another aliquot the a-and ,8-lipoproteins were quickly separated. The specific activity of free cholesterol (FC) in the lipoproteins isolated by the two methods are shown for comparison in Table II . Within each ultracentrifugal plasma sample no consistent differences were noted in the specific activities of the FC of HDL, VLDL, and LDL, whereas systematic differences did exist between the specific activities of the a-and ,-lipoproteins.
The specific activity vs. time curves of the free cholesterol in a-and B-lipoproteins for subjects 1, 2, and 3 are shown in Figs. 1-3 [3H]cholesterol (Fig. 1, top) . The 3H-#t-FC specific activity decreased in a multiexponential fashion. The 3H-a-FC specific activity increased rapidly reaching a maximum (peak) after '20 min, and then decreased slowly to merge with the 3H-ft-FC after 180 min.
Most notable was the observation that the 'H-a-FC peak specific activity value was considerably lower than the 3H-ft-FC specific activity at 20 min, and remained lower for 180 min. Subject 3 also received VLDL labeled with free [3H]cholesterol (Fig. 2, top) and simultaneously received LDL labeled with free [14C]cholesterol (Fig. 2, bottom) . For both 3H and "4C data, the relationships observed between the a-and jl-FC specific activity curves were the same as those described above for subject 1 (Fig. 1, top) . During the initial 20-30 min of these two experiments a large portion of the radioactivity in the alipoprotein fraction is probably acquired directly by transfer from the labeled VLDL or LDL. Potential explanations of the relatively low peak of a-FC specific activity include: (a) input of unlabeled free cholesterol to HDL from LDL after 3H-VLDL administration or from VLDL after 14C-LDL administration; (b) Input of unlabeled free cholesterol to HDL from tissue (membrane) sources; (c) subcompartments of f3-FC system (VLDL + LDL). This subject's data was simulated under two sets of conditions. First, no exchange of FC occurred between LDL and VLDL as shown in Fig. 6 . To simulate the observed a-FC and j3-FC specific activities and pool sizes, the great majority (90-100%) of the free cholesterol leaving the VLDL and LDL compartments was found to be transported directly to HDL. Also, the rate constants L(4, 22) and L(4, 21) were found to be identical (0.028 min-'). The ,@-FC fit was optimal with a-lipoprotein as its only source of free cholesterol. Second, the data were simulated assuming various degrees of bidirectional transport between VLDL and LDL. The results obtained were the same as above in that to fit the data (a) almost all (90-100%) FC leaving the VLDL + LDL fraction was transferred directly to HDL, (b) an optimal fit of the ,B-FC was obtained with a-FC as its only precursor, and (c) the ,B-FC fit could not be improved upon when the rate constants L(4, 22) and/or L(4, 21) were varied from 0.028 min-'. Because the magnitude of FC transport pathways between VLDL and LDL-FC were not defined by the data and because their presence had no effect on the remaining structure of the model or on the parameters of the a-FC and total j3-FC fractions, the modeling was performed without these pathways.
As shown in Fig. 6 , a pathway, R(6, 21), from LDL FC to a nonplasma compartment, C(6), was incorporated into the model to represent the process for cellular uptake of LDL FC (17) . The rate constant L(6, 21) was fixed at a value determined for LDL Apo B from the literature (18, 19) . Although our study did not allow the detection of R (6, 21), its incorporation into the model was found to not effect any part of the solution. The pathway R(6, 21) was included in the model because it's existence has been clearly documented by others and for comparison with the magnitude of the new pathways that were defined by the study.
The a-HDL-free cholesterol, C(4), was initially modeled as a single compartment as shown in Fig. 6 . Two important observations were made. First, it was found that the initial steep decline in a-FC specific activity after HDL-free ['4C]cholesterol administration (Figs. 1, bottom, and 3) could not be attributed solely to transfer of FC from the a-to the ,B-fraction. To simulate this steep decline it was necessary to incorporate a pathway from HDL-FC to a nonplasma compartment, designated as G (12) . Second, the major pathway of FC transport from nonplasma to plasma compartments was found to be into HDL. This pathway, L(4, 12), and not the presence of HDL subcompartments or the input of unlabeled VLDL or LDL-FC to HDL, was necessary to simulate the low peak in a-FC specific activity shown in Figs. 1 (top) and 2 (top and bottom). A relatively small (<15% of that into HDL) flux of free cholesterol from a nonplasma pool directly into LDL or VLDL could not be excluded, but such an addition did not improve the fit of the data. In summary, bidirectional transport of FC be- 6 . There was a short delay (10-11 min) in the incorporation of 14C into free cholesterol accounted for by G(11) . This delay time most likely makes up part of the longer delays, C(7) and G(10), found in previous modeling of the bile acid and biliary cholesterol pools after labeled mevalonic acid (4) . The parameter L(1, 1) could not be defined by the data and was fixed at 0.020/min based on the average from previous studies (4) .
The need for a relatively slowly exchanging compartment, C(6), appeared in the experiments extended beyond 9 h (subjects 2, 4, and 5). Without C(6), the simulated specific activities in the a-and fi-FC fractions declined more rapidly after 9 h than the observed specific activities. The synthesis of cholesterol in this presumed extrahepatic tissue pool could not be determined as it has been in more prolonged experiments (20) , and U6 has been fixed at zero.
The rate of cholesterol synthesis, U1, in subject 1 with a total bile fistula was fixed at 5.5 jmol/min, the measured rate of bile acid plus biliary cholesterol excretion. The rate of cholesterol synthesis in subjects 2-5 was assumed to equal 2.1 ,umol/min (21) . The specific activity fits and parameter values were not sensitive to this assumption. For example, a twofold change in U1 only affected the parameters L(4, 12) and L (12, 4) , and the maximum change was <10%. The compartment from which cholesterol is lost from the body (bile acid and biliary cholesterol precursor pools) could not be identified precisely from the present experimental data. However, the slow fractional rate constant of C(6) of -0.0006 min-' excludes this pool as the bile acid and/or biliary cholesterol precursor. The latter have rate constants of -0.015 min-' (4). Other studies have shown that HDL-FC is excreted at a more rapid rate in bile than LDL (5-7) or VLDL-FC (unpublished observations) and also that the bile acid and biliary cholesterol precursor pools are directly supplied, in part, by NSC (4). Because C(12) exchanges FC with HDL and not directly with LDL or VLDL, receives newly synthesized cholesterol (NSC) and has a rate constant of -0.010 min-', it could conceivably be comprised in part by the hepatic bile acid and biliary cholesterol precursor pools. Therefore, the output from the free cholesterol model shown in Fig. 6 has been arbitrarily placed at C(12); however, the data Estimated from the literature for subjects [2] [3] [4] [5] with intact enterohepatic circuits (21) ; determined experimentally in subject 1 as the sum of bile acid plus biliary cholesterol excretion from the complete bile fistula. In all subjects, U(1) = R(0, 12) = R(12, 1).
I Parameter value±FSD (FSD = SD X 100 -. parameter value).
shown in Figs. 1-5 were fit equally well with essentially identical solutions when the output was changed from C(12) to C(6), C(4), or C(15).
Model parameters. The fluxes derived from compartmental analysis are shown in Table III . The total free cholesterol flux out of HDL was very large and ranged from 69 to 183 ,umol/min. Approximately one half of this was transported to the #-fraction, R (22, 4) plus R(21, 4). About two-fifths of the total flux from the HDL-FC was into the nonplasma compartments, C(6) and C(12), predominantly via R (12, 4) . To fit the data, virtually all the f-FC exchanged only with HDL. In subjects 1 and 3, in whom the experiments were limited to 9 h, the relatively slow exchanging C(6) was poorly defined as reflected in the large FSD associated with this compartment.
The large amount of free cholesterol that recycles (exchanges) between HDL and the tissue and ,B-fractions is highlighted by comparison with the flux via the pathway R(6, 21). The latter pathway represents the 0.5 to 0.8 gmol/min of LDL-FC, which is internalized by tissues via the uptake of LDL Apo B. Although of large magnitude, the FC exchange pathways between HDL and both C(12) and the ,-fractions are well defined, as reflected by their low FSD. The rate constants and delay times derived from compartmental analysis are shown in Table IV . All pool sizes derived from the analysis are shown in Table  V . The extent of variation in the size of C(12), the rapidly exchanging tissue pool, was small and ranged from 4,491 to 6,901 umol. In most subjects the size of C (12) was approximately twice the size of the total plasma FC pool. Confidence was gained in the model structure by the finding of similar values between subjects for most of the adjustable rate constants and masses. This similarity is remarkable because of the (18, 19) . In subject 1 with a complete bile fistula, L(6, 21) was fixed at 0.0006 per min in accord with recent reports of a twofold increase in LDL Apo B FCR in subjects taking cholestyramine (32), medication with physiologic effects similar to those of a bile fistula. Calculated from the plasma concentration and plasma volume as 4.5% of kilograms body weight. The calculated values were then used to constrain the a-and /3-free cholesterol compartment sizes in the kinetic analysis. 
DISCUSSION
The data of the present report have provided some new information on several aspects of lipoprotein free cholesterol metabolism in man. It is quite clear that there are kinetic differences in the behavior of the FC in the a-and ,B-lipoproteins. The observed differences between the specific activities of free cholesterol in the a(HDL) and ,B(VLDL + LDL) lipoproteins were present after rapid separation of the lipoproteins by precipitation from plasma within 10 min of venipuncture, but not after h of isolation from plasma in the ultracentrifuge (Table II) . Extensive ex vivo exchange apparently occurs during ultracentrifugation. After the administration of ["4C]mevalonic acid, a-lipoprotein FC specific activity remained higher than the ,-lipoprotein FC for -8 h (Figs. 4 and 5) . Conversely, the specific activity of a-lipoprotein FC remained considerably lower than the fi-FC for 3 h after LDL-and VLDL-labeled free cholesterol were administered (Figs. 1, top, and 2 ). The multicompartmental model shown in Fig. 6 The simulation analysis showed that almost all 1-free cholesterol was transferred to HDL from where it could leave the plasma or cycle back to the ,B-fraction. The transport rate of LDL-free cholesterol to tissue via the Apo B pathway (0.5-0.8 umol/min) was miniscule compared with the rate of FC transport from LDL to HDL (47-90 ,umol/min). Interestingly, the free cholesterol in both Apo B-rich lipoproteins, VLDL and LDL, appeared in a similar fashion in HDL (Fig.  2) . The corresponding fractional rate constants, L(4, 21) and L (4, 22) , were identical. Preliminary in vivo studies (unpublished observations) have shown that VLDL-FC and LDL-FC also appear (probably via HDL) in a similar fashion in erythrocytes, bile acids, and biliary cholesterol, supporting the conclusion that LDL-and VLDL-free cholesterol are metabolically and kinetically homogeneous. However, homogeneity of FC in these Apo B-rich particles cannot be proven until a method is available for the rapid isolation of VLDL from blood after venipuncture. The availability of such a technique could also help determine if plasma VLDL contains significant quantities of newly synthesized free cholesterol, which may be secreted with nascent VLDL from the liver and/or intestine.
When LDL labeled with FC was incubated in vitro with erythrocytes, in the absence of other blood components complete exchange of FC was observed (22, 23 It is likely that a portion of compartment 12 is located in the liver and is comprised of the bile acid and biliary cholesterol precursor pools. These precursor pools are known to contain '500 ,um FC (minimum estimate), receive NSC directly, exchange preferentially with HDL-FC, and have turnover times of 1-1.5 h (4-7). All of these kinetic features are compatible with those of C (12) . The studies of Gould et al. (26) , using
[14C]acetate in man to label cholesterol also suggested the presence of a hepatic cholesterol pool (in exchange with plasma FC) with a turnover time of 1.5 h (26) . In summary, the data supports the conclusion that C(12) is extravascular cholesterol, part of which is in the liver. Compartment 6, a less rapidly miscible pool of cholesterol compared with the others in this model, was necessary to simulate the plasma FC specific activities after 9 h and up to 3 d after the injection of labeled compounds. The approximate size and turnover time of C(6) was 20,000 ,um and 27 h, respectively, suggesting that it could contain several metabolic pools including plasma esters and possibly erythrocyte cholesterol.
Undoubtably other small and large pools of cholesterol exist that are not shown in Fig. 6 , such as pools 2 and 3 of Goodman et al. (27) . However, preliminary simulation analysis has shown that the magnitude of cholesterol flux to and from these pools and plasma would be small relative to the fluxes between pools shown in Fig. 6 . Pools 2 and 3 of Goodman et al. (27) , had no appreciable effect on the decay curves for several days (or weeks) after injection of the labeled compounds.
The nature of the process that mediates the exchange of free cholesterol between HDL and tissues is open to speculation. Recent in vitro studies have shown that HDL can promote free cholesterol efflux from tissues (28) (29) (30) . HDL is heterogeneous in this regard; HDL3 and the plasma fraction of density > 1.21 (VHDL), both of which are enriched with Apo A-I, are the components of plasma that are potent acceptors of tissue free cholesterol (29) . In our study we found no kinetic evidence for heterogeneity of the free cholesterol in HDL. These observations can be unified assuming that the specific acceptor "particle" mediates FC removal from tissue membranes; after appearing in plasma, FC on the acceptor becomes homogeneous with FC in the entire HDL class of particles. Alternatively, HDL-FC may be metabolically heterogeneous and the FC exchange between HDL subclasses could occur at a rate too rapid to be detected by the present kinetic analysis and experimental design. It is also possible that the acceptor particle is not involved in the bidirectional exchange of FC between HDL and tissues, which was observed in our studies. Mechanisms for FC exchange and transport may exist in addition to the proposed acceptor particle. However, in light of current knowledge it seems reasonable to postulate that the acceptor particle does mediate the in vivo tissue efflux measured in the present study. There could be another class of particles that mediates the reverse process (HDL-FC to tissue FC), or the acceptor particle could mediate both limbs of the exchange process. Most likely, FC is constantly exchanging between HDL and tissue membranes; this exchange is mediated by the acceptor particle(s), and large net differences between efflux and influx can be detected only after a pertubation such as that induced in vitro by loading macrophages with cholesterol (30) or by loading HDL with FC (31) .
